Carotid stenosis is the cause of about one in 12 strokes or TIAs.
Carotid stenosis is usually silent until it causes a transient ischaemic attack.
In this presentation on 30 April, vascular surgeon Dr Shannon Thomas will explain that the key to better health outcomes is suspecting the condition, investigating early and knowing when and how to treat, including when referral for surgical intervention is appropriate.
How do the CPD options work?
- Attend the webcast and earn 2 hrs CPD in the Educational Activities category by attending the webcast lecture and completing the evaluation (RACGP & ACRRM approved)
- Complete the optional post-webcast quiz and earn 0.5 hrs CPD in the Reviewing Performance category (RACGP & ACRRM approved)
- Complete the optional Patient Case Review and earn a further 0.5 hrs CPD in the Reviewing Performance category (RACGP approved*)
- Undertake the optional Micro Audit and gain 1 hrs CPD in the Measuring Outcomes category (RACGP approved*)
- We are working with the ACRRM to have the Patient Case Review (RP) and Micro Audit (MO) approved for its members as well, however ACRRM’s approval processes are somewhat slower! Until then, ACRRM members can claim the same CPD as last year.
Other professions can self-claim up to 4 hrs CPD.
Attendees will receive Certificate of Attendance approx. two weeks post-webcast
Don’t miss out, REGISTER NOW.
Topics include:
TIAs and Carotid Stenosis
Dr Shannon Thomas – Vascular Surgeon; Specialist Vascular Surgeons, Prince of Wales Hospital, Sydney
Carotid stenosis is the cause of about one in 12 strokes or TIAs.
The challenge is, of course, carotid stenosis is generally silent until it causes one of these ischaemic consequences. So, as Dr Shannon Thomas will discuss in this talk, the key to better health outcomes is suspecting the condition, investigating early and knowing when and how to treat, including when referral for surgical intervention is appropriate.
Using the New RSV Vaccine in Practice
A/Prof Michael Woodward AM – Geriatrician; Head, Aged Care Research and Memory Clinic, Austin Health, Melbourne
We used to think that Respiratory Syncytial Virus mainly affected children, causing usually a fairly mild, cold-like illness. No more.
We now know that RSV infection can cause significant morbidity even in adults, particularly older adults and is not only common but highly infectious and can cause repeated infections throughout life. In this talk, Associate Professor Michael Woodward will provide an update on what is now known about this virus in Australia as well as advising what is coming in terms of prevention and treatment of RSV, including vaccines which it is hoped will soon become available for those vulnerable to severe RSV infection.
Functional Gastrointestinal Disorders in Infants (FGIDs) – Practical Advice for GPs
Dr Rupert Hinds – Consultant Gastroenterologist; Monash Children’s Hospital; Senior Lecturer, Monash University
Functional gastrointestinal disorders, like colic, reflux and constipation, are common in infants.
But despite being common, and almost always being benign, these disorders cause a disproportionate amount of distress among concerned parents who will often present, desperate for a diagnosis and treatment. Hear how paediatric gastroenterologist, Dr Rupert Hinds manages these presentations in the real world – the history, assessment, reassurance and advice, and in particular how to identify any red flags that may suggest an underlying pathology.
HSDD – What is it & How is it Managed?
Dr Ginni Mansberg – GP; Consultant, Presenter, Author, Speake
Hormones – especially oestrogen and testosterone influence female sexual desire.
Testosterone declines with age. This is just one contributor to the complex interplay of bio-psycho-social factors that impact on midlife women’s sexual health. Transdermal testosterone treatment specifically for women is now available in Australia. Its indication is a diagnosis of Hypoactive Sexual Desire Disorder in POST menopausal women. We have good tolerability and efficacy data for 24 months of use. Total testosterone and SHBG levels need to be taken at 8am before starting, and again 3-6 weeks after commencing testosterone supplementation. And then 6 monthly, together with a clinical review to exclude hyperandrogenism. There is excellent evidence for efficacy in improvements in sexual wellbeing across a number of domains.
Date:
Tuesday 30th April
Time:
7pm – 9pm AEST (NSW, VIC, TAS, ACT, QLD)
6:30pm – 8:30pm ACDT (SA, NT)
5pm – 7pm AWST (WA)
